Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of... – Animal cell – per se – expressing immunoglobulin – antibody – or...
Reexamination Certificate
2006-05-09
2006-05-09
Canella, Karen A. (Department: 1642)
Chemistry: molecular biology and microbiology
Animal cell, per se ; composition thereof; process of...
Animal cell, per se, expressing immunoglobulin, antibody, or...
C435S334000, C435S343100, C435S344100, C435S348000, C530S388100, C530S388220, C530S388730, C530S388850
Reexamination Certificate
active
07041499
ABSTRACT:
The present invention relates to nucleic acid molecules encoding cell surface receptors on immune cells and the characteristic peptides that comprise these receptors. More specifically, the present invention concerns the use of synthetic and recombinant peptides comprising natural killer (“NK”) cell surface receptors. The synthetic and recombinant peptides are used to generate monoclonal antibodies that bind a specific NK cell surface receptor called CS1. The binding of the monoclonal antibody to the NK cell surface receptor leads to NK cell activation. In a particular embodiments of the present invention, the monoclonal antibodies are utilized in a method that inhibits the growth of tumor cells.
REFERENCES:
patent: 4554101 (1985-11-01), Hopp
patent: 5440013 (1995-08-01), Kahn
patent: 5446128 (1995-08-01), Kahn
patent: 5475085 (1995-12-01), Kahn
patent: 5618914 (1997-04-01), Kahn
patent: 5670155 (1997-09-01), Kahn
patent: 5672681 (1997-09-01), Kahn
patent: 5674976 (1997-10-01), Kahn
patent: 5710245 (1998-01-01), Kahn
patent: 5770387 (1998-06-01), Litwin et al.
patent: 5840833 (1998-11-01), Kahn
patent: 5859184 (1999-01-01), Kahn et al.
patent: 5929237 (1999-07-01), Kahn
patent: 6114143 (2000-09-01), Eda et al.
patent: WO 99/63088 (1999-12-01), None
patent: WO 01/46260 (2001-06-01), None
Coffey, A.J. et al., Host Response to EBV Infection in X-Linked Lymphoproliferative Disease Results From Mutations in an SH2-Domain Encoding Gene, Nature Genetics, vol. 20, pp. 129-135, Oct. 20, 1998.
Davis, S.J., et al., CD2 and the Nature of Protein Interactions Mediating Cell-Cell Recognition, Immunological Reviews, vol. 163, pp. 217-236, 1998.
Kato, Kazunori, et al., CD48 is a Counter-Receptor for Mouse CD2 and is Involved in T Cell Activation, J. Exp. Med., vol. 176, pp. 1241-1249, Nov. 1992.
Kumaresan, Pappanaicken R., et al., Structure of the Human Natural Killer Cell Receptor 284 Gene and Identification of a Novel Alternative Transcript, Immunogenetics Aug. 18, 2000.
Mathew, Porunellor A., et al., Cloning and Characterization of the 2B4 Gene Encoding A Molecule Associated With Non-MHC-Restricted Killing Mediated by Activated Natural Killer Cells and T Cells, The Journal of Immunology, vol. 151, pp. 5328-5337, Nov. 15, 1993.
Sayos, J. et al., The X-Linked Lymphoproliferative-Disease Gene Product SAP regulates Signals Induced Through the Co-Receptor SLAM, Nature, vol. 395, pp. 462-469, Oct. 1, 1998.
Sewell, William A. et al., The Human LFA-3 Gene is Located at the Same Chromosome Band as the Gene for its Receptor CD2, Immunogenetics, vol. 28, pp. 278-282, 1988.
Smith, Glenn M., Detection of a Soluble Form of the Leukocyte Surface Antigen CD48 in Plasma and its Elevation in Patients With Lymphoid Leukemias and Arthritis, Journal of Clinical Immunology, vol. 17, pp. 502-509, 1997.
Stepp, Susan E., et al., Gene Structure of the Murine NK Cell Receptor 2B4: Presence of Two Alternatively Spliced Isoforms With Distinct Cytoplasmic Domains, Eur. J. Immunol., vol. 29, pp. 2392-2399, 1999.
Tangye, Stuart G., et al., Cutting Edge: Human 2B4, an Activating NK Cell Receptor Recruits the Protein Tyrosine Phosphatase SHP-2 and the Adaptor Signaling Protein SAP, The Journal of Immunology, vol. 162, pp. 6981-6985, Jun. 15, 1999.
Van Der Merwe P. Anton, et al., Human Cell-Adhesion Molecule CD2 Binds CD58 (LFA-3) With a Very Low Affinity and an Extremely Fast Dissociation Rate but Does not Bind CD48 or CD59, Biochemistry, vol. 33, pp. 10149-10160, 1994.
Van Der Merwe, P. Anton, et al., The NH2-Terminal Domain of Rat CD2 Binds rat CD48 with a Low Affinity and Binding Does not Require Glycosylation of CD2, Eur. J. Immunol., Vol. 23, pp. 1373-1377, 1993.
Weiss, A., et al., Signal Transduction by Lymphocyte Antigen Receptors, Cell, vol. 76, pp. 263-274, Jan. 28, 1994.
Vita, C., et al., Novel Miniproteins Engineered by the Transfer of Active Sites to Small Natural Scaffolds, Biopolymers, vol. 47, pp. 93-100, 1998.
Weisshoff, H., et al, Mimicry of Beta II-Turns of Proteins in Cyclic Pentapeptides With One and Without D-amino Acids, Eur. J. Biochem., vol. 259, pp. 776-788, 1999.
Johannesson, P., et al., Bicyclic Tripeptide Mimetics With Reverse Turn Inducing Properties, J. Med. Chem., vol. 42, pp. 601-608, 1999.
Boles Kent
Mathew Porunellor A.
Canella Karen A.
Jackson Walker L.L.P.
University of North Texas Health Science Center
LandOfFree
Immuno activation of CS1 receptor in natural killer cells to... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immuno activation of CS1 receptor in natural killer cells to..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immuno activation of CS1 receptor in natural killer cells to... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3532159